Posted: November 7th, 2014 | Author: Lindsay | Filed under: Basics, In the News | Tags: Devices, digital health, DoseSpot, e-Prescribing Integration, In The News, mhealth, Sensors, TechCrunch, Wearables | No Comments »
In today’s health space, there is no doubt that consumer expectations for sensor-laden gadgets are at an all-time high. While the wearables market continues to grow at a rapid pace, Sensoplex CEO Hamid Farzaneh states that there is still plenty of room for improvement. In a recent TechCrunch article, Farzaneh acknowledges the amazing accuracy of high-quality sensors, yet wearable products continue to be clunky and generate poor user experience. To make consumers’ wearable experiences as informative and beneficial as possible, Farzaneh tackles some major myths and misconceptions surrounding the health wearables market:
1. Battery LifeÂ
Buyers of wearables are always looking for newer, sophisticated and accurate sensors that tend to require a lot more power—and consequently, a lot more space. The current state of battery technology means that any wearable with more than an accelerometer will need a decent-sized battery that must be recharged every few days. Such a battery will take up a significant portion of the available space in a wearable device. The more “bells and whistles†associated with a wearable, therefore, will greatly increase its overall size—leading to potential problems for consumers seeking small and sleek wearables.
2. The “Invisible Wearable”
The successful wearable, in the eyes of many wearable advocates, is one that is practically invisible. This notion has fed into announcements (including New York Times articles) about tattoo, stamp-sized or flexible sensors and devices that one can stick onto his/her skin to collection motion or bio-information. The reality is that sensors by no means complete systems—they simply capture raw data. The kind of ultra-thin devices being talked about simply cannot house the necessary batteries to power sensors that accurately provide biofeedback information that consumers are actively looking for.
3. Miracle mHealth SensorsÂ
Mhealth products are currently among some of the bestselling consumer sensor products today. Eliminating everyday health-related nuisances for many individuals, mhealth products enable consumers to measure blood pressure without a cuff or take blood sugar readings without a finger prick—and they rake in over $10 billion annually. While there is much R&D within this market, there has yet to be an FDA-approved product. Additionally, mhealth products leave room for significant “noise.†For products that measure blood oxygen content and skin conductivity, for example, applications to different wrist sizes and bone structures can result in significant reading variations.
For a full list of Farzaneh’s myths and misconceptions pertaining to the wearables market, check out the TechCrunch article here!
SOURCE: TechCrunch
About DoseSpotÂ
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: October 31st, 2014 | Author: Lindsay | Filed under: In the News, Telehealth | Tags: Apple, Connected Health, Devices, digital health, DoseSpot, e-Prescribing Integration, e-Prescribing Software, Google, HealthBeat 2014, ipad, VentureBeat | No Comments »

Among the various verticals that Apple’s iPad now occupies, recent discussions suggests that the healthcare space may be benefiting the most. The topic of iPad use in healthcare surfaced at VentureBeat’s HealthBeat 2014 conference Tuesday, where Drchrono’s Daniel Kivatinos, Direct Dermatology’s Dr. Angela Walker and Welltok’s Michelle Snyder discussed the use of mobile technology like the iPad and Google Glass in today’s medical realm.
According to Kivatinos, Walker and Snyder, the iPad has had a huge impact on medical practices because it can be used for physician-oriented tasks previously restricted to desktop computers. After the official iPad launch in 2010, many doctors soon gravitated towards the device and incorporated its use into everyday medical practices.
Dr. Walker of Direct Dermatology added that she didn’t fully adopt the iPad in her dermatology practice until the iPad mini came out—she liked how it fit nicely in her white coat’s pocket. Welltok’s Snyder then pointed out that Drchrono was the first to create an EHR app for Google Glass. Some questions still remain around the use of Google Glass in the healthcare vertical, as privacy issues are teased out. The benefits, however, seem to be plentiful at the moment.
Kivatinos described Google Glass’ efficacy, in that quickly pressing Glass’ “record†button to capture a portion of a patient visit could be wildly helpful for both doctor and patient. Walker added that Google Glass might also be useful in patient education: “[surgery is] a discipline where doctors’ hands might be busy a lot and Glass can be helpful…In any setting where your hands are tied, it can be useful.†As discussions surrounding iPads and Google Glass in the medical field continue to multiply, one overall conclusion is very clear: mobile devices are changing the way healthcare professionals run their practices.
Did you miss out on HealthBeat 2014? Catch up on some interesting chats and happenings here!
SOURCE: VentureBeat
About DoseSpotÂ
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: October 23rd, 2014 | Author: Lindsay | Filed under: Basics, In the News, Telehealth | Tags: digital health, DoseSpot, e-Prescribing Integration, Ebola, Healthcare, healthIT, Public Health, technology, Tele-ICU, telehealth, Vidyo | No Comments »

As Ebola enters the United States and case numbers continue to rise, the ever-challenging and pressing question among health professionals remains the same: how is one to deliver care effectively without risking disease spread? With the help of Vidyo, a software company specializing in visual communications, a Nebraska medical center may have the answer.
About a month ago, Vidyo’s video conferencing platform was used in the Biocontainment Patient Care Unit at the Nebraska Medical Center—one of only four units in the U.S. equipped to handle these types of cases. It was here that medical professionals were treating Dr. Richard Sacra, a Massachusetts physician who contracted Ebola in Liberia while working in child delivery. The video conferencing unit was used to help doctors treating Sacra interact with the patient and connect him to family and friends. The Medical Center, located in Omaha, NE, has worked with New Jersey-based Vidyo since 2011.
With the Ebola virus becoming a dangerously salient international issue, the ability to remotely treat infectious diseases via Tele-ICU applications—equipped with medical devices like otoscopes, dermatoscopes and labs— is becoming more important than ever. To prevent the spread of infections in sterile settings, Tele-ICU enables hospitals to establish centralized monitoring facilities to address patient needs during overnight hours. Now afforded the option to evaluate a presumed ill patient remotely via video, many healthcare professionals are hopeful that such measures will protect caregivers from exposure, permit a quick response to treatment and protect the public from potential epidemics.
For more information on how digital health is addressing disease epidemics, check out MobiHealthNews’ article here.
About DoseSpotÂ
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: October 3rd, 2014 | Author: Lindsay | Filed under: Basics, In the News, Venture funding | Tags: accelerators, Athenahealth, Boston, care delivery, DoseSpot, e-Prescribing, e-Prescribing Integration, EHR software, healthcare disruption, healthIT, healthtech, more disruption please, Smart Scheduling, startups | No Comments »

Calling all Beantown startup followers: the Massachusetts healthtech scene is expanding! Watertown-based Athenahealth has announced that its new accelerator for health IT startups is now open for business. The “More Disruption Please†(MDP) Accelerator went into beta in June when it began working with a single startup, Smart Scheduling, but is now inviting health IT startups to apply for participation.
Based on a mission to “drive connectivity and innovation across the continuum of care,†MDP is the third phase of a 2010 effort to connect with and promote startups that seek to address areas of concern in the health care delivery system beyond the electronic health record (EHR). The perks of joining MDP, one might ask? Athenahealth will provide venture capital to companies through the accelerator. Aside from funding, portfolio companies get free office space at Athenahealth’s super chic Watertown headquarters and ongoing mentorship from Athenahealth experts.
Athenahealth says the accelerator will accept applicants on a rolling basis, with an anticipated residency period of roughly 8 to 12 months. More information about MDP can be found on Athenahealth’s “More Disruption Please†page.
SOURCES: VentureBeat and Athenahealth
About DoseSpot
DoseSpot is a Surescriptsâ„¢ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: September 22nd, 2014 | Author: Lindsay | Filed under: Basics, In the News, Incentives, Public Policy, Telehealth | Tags: Big Data, consumer health, Cost Transparency, DoseSpot, e-Prescribing Integration, e-Prescriptions, Medical, medication adherence, mhealth, Remote Care, telehealth | No Comments »
With the 2014 calendar year coming to a close in just a few months (gasp!), HealthWorks Collective, an online health and editorial community, has released its list of health trends to keep an eye on through 2015. Think your predictions are spot on? Take a look below to see what’s on tap for the U.S. healthcare industry:
1. More providers will be hiring health coaches.
Chronic conditions in the U.S. continue to increase—so will employment. Health coaches fill a unique demand for managing chronic conditions, as they engage with patients one-on-one and keep clinical staff informed about financial or family concerns, marital problems, treatment plan adherence, etc.
2. Healthcare mobile apps on the rise.
With the release of Apple’s new Healthkit along with a slew of other mobile-friendly health apps, this trend is likely to continue for the foreseeable future. Patient-centered apps for monitoring aspects of health like calorie-counting and heart rate are gaining popularity at a quick pace and healthcare systems will continue developing and implementing apps to improve patient experience.
3. New care and payment models will expand.
Insurance companies, Medicare and Medicaid programs will continue to push for more relationships with accountable care organizations (ACOs). Different payment models will also be proposed—many healthcare professionals anticipate a trend towards “shared savings†incentives with physicians based on lowering cost and improving care quality.
4. Big Data will play a key role in patient care.
Electronic health records and other emerging technologies enable providers to automate processes and capture vital clinical data. These technologies, however, are limited in not being open to innovation. By the end of 2014, expect provider advocacy for making application interfaces open-source so they can be used to create new and exciting programs.
5. Healthcare comes to the home.
Technological advancements and increasing healthcare access will lead to more remote care services. This means that more patients can be monitored and coached to health at any time and place. “At-home healthcare†will increase patient quality of care, improve patient satisfaction, and reduce costs.
6. Increasing transparency.
Expect the level of transparency demanded from healthcare systems to increase, along with the production of tools to help inform patients. The price of treatments, procedures and clinicians along with performance metrics and hospital outcome reports will all be made available for patients to peruse at the click of a mouse.
7. Partnerships for care delivery will expand.
Healthcare partnerships will soon include community-based groups such as social service agencies, gyms and other non-healthcare service providers. As the industry strives to better address population health management, expect more unconventional approaches to healthcare such as church-based group care sessions, outdoor exercise at nature centers, reduced price health care transportation services, etc.
Source: HealthWorks Collective
For more information on the aforementioned trends, check out HealthWorks Collective’s full article here.
About DoseSpot
DoseSpot is a Surescriptsâ„¢ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: September 2nd, 2014 | Author: Lindsay | Filed under: Basics, In the News, Telehealth | Tags: DoseSpot, e-Prescribing Integration, HIMSS, telecommunication, telehealth | No Comments »

According to HIMSS Analytics’ recently released 2014 U.S. Telemedicine study, two-way video is proving to be a key component of value-based care for the foreseeable future. This study, considered the first installation of HIMSS Analytics’ new “Essentials Briefs†series, tracks a technology strategy with increasing popularity among healthcare providers seeking ways to deliver better—and more cost-effective— care to larger patient populations. HIMSS reports a shift from volume-based to value-based care within many organizations, and telemedicine technologies are aiding in this transition.
Noteworthy findings from HIMSS Analytics’ Study include:
- 46% of respondents utilize up to four telemedicine technologies within their respective organizations.
- Two-way video/webcam services are the most widely used (58%) and most widely considered (67%) for those making a telemedicine investment.
Polling both hospitals and private practices, HIMSS’ first Brief installation offers insights into how and why U.S. providers are adopting telemedicine tools by addressing specific topics such as integration with electronic health records.
Source: Healthcare IT News and HIMSS Analytics
For more information on current telemedicine adoption trends, check out an overview of the HIMSS Analytics 2014 Telemedicine Study here
About DoseSpot
DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: August 25th, 2014 | Author: Lindsay | Filed under: Basics, Controlled Substances, In the News | Tags: Controlled Substances, DoseSpot, Dr. House, e-Prescribing, e-Prescribing Integration, EPCS, Pain Management, Recovery, UMCPP | No Comments »

With the ability to e-Prescribe controlled substances soon to be a widespread reality in the U.S., pain medication management is currently a discussion “hot topic” among many clinicians. Hospital staff members at University Medical Center of Princeton at Plainsboro (UMCPP)—the former stomping ground of Dr. Gregory House—are no exception. In need of a major floor plan facelift a few years ago, the UMCPP team visited the design drawing board to revamp patient rooms. What they came away with was a mock hospital room to test with real patients. Complete with a guest sofa, outdoor view, novel drug dispensary, and easy-to-access restroom, this hospital room became an evaluation site for patients recovering from knee and hip replacements. Healthcare professionals at UMCPP hoped that this new layout would reduce slip-and-fall accidents, medication mix-ups, and other hospital-related mishaps.
Compared to the old hospital rooms, patients staying in the mock room rated food and nursing care higher, although meals and care were the same. The most compelling results? Patients asked for 30 percent LESS pain medication in the mock room. According to many medical professionals, reduced pain is thought to lead to shorter recovery time, reduced hospital stays, and lower hospital costs.
What were once premature and isolated statistics are now a success for UMCPP. The mock patient room became a reality in 2012, when UMCPP opened its new $523 million, 636,000 square-foot hospital in Plainsboro, New Jersey. Since the grand and much-needed opening, patient satisfaction ratings have been in the 99th percentile—a major leap from the 61st percentile prior to the move. With infection rates at an all-time low, UMCPP will keep improving hospital care—and dispensing less pain meds.
Sources: The New York Times and HC+O
For more details on UMCPP’s innovative patient rooms, check out a floor plan here, in the New York Times’ recent article.
To see a list of top U.S. hospitals that are tackling the issue of pain management, check out Becker’s Hospital Review here.
About DoseSpot
DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: July 31st, 2014 | Author: Lindsay | Filed under: Basics, In the News | Tags: Big Data, DoseSpot, e-Prescribing Integration, genetics, Google, health, HIPAA, technology | No Comments »

SOURCE: Vanity Fair
We’re surrounded by hundreds of health terms on a daily basis, but what does it truly mean to be “healthy� Google X, the research branch of Google, may soon have an answer for us. As first reported by the Wall Street Journal and later confirmed by Google, Google X has embarked on a bio-medical research project called ‘Baseline Study’ that will aggregate anonymous genetic and molecular information. The Study will initially test 175 people to solidify data collection methods—with thousands more to come— to create an accurate picture of the healthy human.
The 175-person pilot group will go through extensive medical testing, including blood and saliva analyses. Once completed, the Baseline Study team will review all samples with researchers at Duke University and Stanford University, the anticipated sites for the eventual, large-scale study.
In response to privacy concerns, Google told the Wall Street Journal that any data collected for Baseline will be anonymous, used only for medical purposes, and will not be shared with insurance companies. Baseline’s aim is to act as a reference database for the chemistry of a well-machined, healthy body—and, subsequently, identify abnormalities much earlier. With the birth of Baseline, the hope is that the medical community will move towards prevention rather than treatment in response to disease.
Sources: The Next Web and Business Insider
For more information on Google’s groundbreaking health plans, check out this article by TIME Magazine: http://time.com/3045429/google-baseline-study-human-health/
About DoseSpot
DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: July 30th, 2014 | Author: Jodi | Filed under: Basics, In the News, Newsletter | Tags: e-Prescribing, e-Prescribing Integration, EHR software, ONC, surescripts | No Comments »
Earlier this month, the Office of the National Coordinator for Health Information Technology (ONC) released a Data Brief on trends in e-Prescribing as measured over the past few years. The Data Brief available here highlights compelling statistics surrounding e-Prescribing growth and adoption.  Here is what we found most riveting:
10 states with the highest e-prescribing rates as of April 2014:
- Minnesota — 100 percent
- Iowa — 95 percent
- Indiana — 95 percent
- Massachusetts — 94 percent
- South Dakota — 90 percent
- New Hampshire — 87 percent
- North Dakota — 87 percent
- Wisconsin — 87 percent
- Kentucky — 85 percent
- Oregon — 84 percent
10 states with the lowest e-prescribing rates as of April 2014:
- Alaska — 48 percent
- Nevada — 50 percent
- California — 53 percent
- New Jersey — 54 percent
- New York — 59 percent
- Colorado — 60 percent
- Hawaii — 60 percent
- Idaho — 62 percent
- Utah — 62 percent
- Tennessee — 63 percent

- December 2008: Every state with the exception of Massachusetts had physicians e-prescribing using an EHR at a rate  below 20% on the Surescripts Network
- April 2014: Every state had physicians e-prescribing using an EHR at a rate >40% and the majority of states had at least 70% of their physicians e-prescribing using an EHR
About DoseSpot
DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. To request a demo of DoseSpot’s e-Prescribing integration platforms, please visit http://www.DoseSpot.com/.
Posted: July 23rd, 2014 | Author: Jodi | Filed under: Basics, In the News, Newsletter, Telehealth | Tags: DoseSpot, e-Prescribing Integration, healthIT, surescripts certification, telehealth | No Comments »
NEEDHAM HEIGHTS, MA – DoseSpot, an industry leader in e-Prescribing integration platforms for medical and dental software, today announced that Doctor On Demand, a healthcare service that provides Video Visits with board-certified physicians on smartphones and tablets, has completed Surescripts certification through DoseSpot.
“We are thrilled to be working with Doctor On Demand to further enhance their healthcare service platform and offer a comprehensive yet simplified e-Prescribing solution,†said Greg Waldstreicher, President, DoseSpot. “Not only does this streamline operational efficiencies for Doctor on Demand, but e-Prescribing is convenient for patients in need of a prescription,†added Greg.
Doctor On Demand provides Video Visits with board-certified physicians immediately, via smartphones and tablets. Doctor On Demand physicians diagnose, treat, and write prescriptions where clinically appropriate. Visits are only $40. The most common conditions that Doctor On Demand physicians treat include colds, coughs, allergies, infections, fever, rashes, nausea, sports injuries and more.
Through this partnership with DoseSpot, Doctor On Demand physicians are equipped to:
- Safely and efficiently send prescriptions electronically to more than 65,000 pharmacies nationwide;
- Automatically check for dangerous drug-drug and drug-allergy interaction alerts;
- Aggregate prescription history data from community pharmacies in addition to patient medication claims history from payers and pharmacy benefit managers;
- Request information on patient insurance eligibility and formulary at the time of prescribing.
“Telehealth and e-Prescribing share the same objectives; expand access to care, save time, reduce costs and increase efficiency,†said Greg. “This integration proves to be a win for the patient, physician and pharmacist.â€
“We’re focused on providing medical care to people whenever and wherever they need it,†said Adam Jackson, Co-founder and CEO of Doctor On Demand. “In partnership with DoseSpot, it’s even easier for our network of doctors to safely and efficiently prescribe the medications a patient needs to feel better.â€
For more information on e-Prescribing integration platforms and DoseSpot, please visit www.DoseSpot.com.
About Doctor on Demand
Doctor On Demand is a healthcare service that provides Video Visits with board-certified physicians via smartphones or tablets. Patients simply download the Doctor On Demand app, tap a few screens, and are instantly connected to a doctor in their state for a Video Visit. Doctor On Demand delivers services through employers, health systems, health plans, and direct to consumers. Entrepreneurs Adam Jackson and Jay McGraw founded the company in 2013 to improve access to high quality, service-oriented and cost-effective medical care. Doctor On Demand is based in San Francisco. To learn more, please visit www.doctorondemand.com.
About DoseSpot
DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. To request a demo of DoseSpot’s e-Prescribing integration platforms, please visit http://www.DoseSpot.com/.
Read full press release here:Â http://www.prweb.com/releases/2014/07/prweb12039240.htm